We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.02 | -0.82% | 123.00 | 123.77 | 121.2902 | 123.06 | 5,932,928 | 01:00:00 |
From May 2021 to May 2024
By Stephen Nakrosis
Novo Nordisk A/S on Friday said it was recalling certain product samples in the U.S. that had been stored at temperatures below their storage requirements.
The company said 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy were being recalled.
Novo Nordisk hasn't received reports of serious adverse events or injuries related to the recall, it said.
"This recall only impacts product samples and does not impact product that has been broadly distributed to pharmacies or mail-order services," the company said.
The company also said the recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
May 07, 2021 16:38 ET (20:38 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
